Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
2006; Elsevier BV; Volume: 109; Issue: 7 Linguagem: Inglês
10.1182/blood-2006-05-021873
ISSN1528-0020
AutoresIvana Gojo, Anchalee Jiemjit, Jane B. Trepel, Alex Sparreboom, William D. Figg, Sandra Rollins, Michael L. Tidwell, Jacqueline M. Greer, Eun Joo Chung, Min-Jung Lee, Steven D. Gore, Edward A. Sausville, James A. Zwiebel, Judith E. Karp,
Tópico(s)Multiple Myeloma Research and Treatments
Referência(s)